Endourage
SPEAKER
MEDICINE
Proprietary Blend of Hemp Actives Successfully Treats Long Covid
In 2020 as the global COVID pandemic unfolded, I utilized my prior experience in developing therapeutics for HIV (another RNA virus) and developed a novel therapeutic using active ingredients sourced from hemp flower. In June of 2020, we started working with Long Covid patients and found the therapeutic showed promise for these patients. In March 2021 we received full IRB approval for a randomized, placebo-controlled trial of the formulation in human patients diagnosed with Long Covid. In October of 2022 we published the results of the trial in a peer reviewed medical journal. Our formulation had successfully attenuated 8 of the 9 symptoms studied while doubling participants quality of life scores within 28 days, all without any significant adverse events in the trial.
BIO
Michael Steward, MD, was board-certified in Family Practice and specialized in HIV, palliative care and cannabinoid medicine. He is co-founder and Chief Medical Officer of Endourage. Previously, he was Medical Director of Kings Garden in California, Medical Director of A+ Home Health Care in Palm Springs CA, Medical Director of Vitas Innovative Hospice Care, Palm Springs CA, and Owner and operator of Apex Family Medicine, Denver CO. He has been on multiple pharma advisory boards and was involved in the development of several of the HIV protocols still in use today. He was graduated from Vassar College with a degree in Economics, completed his Pre-med at the University of Colorado, studied medical sciences at the University of Colorado School of Medicine and completed his residency at the Mercy Family Medicine Residency in Denver Colorado. He was a family practice and hospice physician for almost 20 years before focusing exclusively on developing cannabis derived therapeutics for the last 8 years. He is a member of the society of cannabis clinicians, The American Academy of Family Practice, and the American Society of Addiction medicine.
View CannMed Resources Below:
ATTENDANCE IS LIMITED. THE OPPORTUNITIES ARE NOT.
